September 30, 2021 | CRISPR, Impetus Digital, Jessica Schwaber, Natalie Yeadon, Solupore, allogeneic therapies, cell engineering, cell therapy, gene therapy, gene-editing, non-viral modalities, precision medicine, viral modalities
Jessica Schwaber, Scientific Director, Cell & Gene Therapy, Avectas, explores her company’s unique cell engineering platform, the recent shift in cell & gene therapy commercial needs, current barriers to realizing the full potential of cell & gene therapy, and much more.
This content was provided by Impetus Digital
Company Details
Latest Content from Impetus Digital
Dr. Phillip Alvelda, CEO and Co-Founder of Brainworks, discusses all things artificial intelligence and machine learning. We also explore the concepts of whole-brain AI systems and ambient biometrics, and how AI-enhanced vital…
Learn how our client successfully carried out a set of three virtual plan of action (POA) discussions, including one internal “Fishbowl” web meeting.
Steven Collens, Chief Executive Officer at MATTER, discusses his professional journey, his work to empower digital health technology startups, and how MATTER is helping businesses define their challenges, identify solutions, and innovate…
Samantha Lippolis, Telehealth Advisor at Sam I am Innovates; Dr. Daniel Fagbuyi, CEO of Erudition; Dr. Brian Block, Health Care Consultant at Brian Block Consulting; Mindy Klowden, Director of Strategic Initiatives at the Colorado Behavioral Healthcare…
Aubrey de Grey, Chief Science Officer at SENS Research Foundation, explores the concept of using biomedical technology and regenerative medicine to postpone aging-derived debilitation and death. We dive into many questions surrounding…
Justin Sutherland, Co-founder and President of Realize Medical, delves into a range of topics around virtual reality (VR) and three-dimensional modeling, including the roles of VR in medical education, training, surgery planning,…
Peter Birch, General Manager (Asia Pacific) at MetaOptima Technologies & host of the “Talking HealthTech Podcast.” joins us to discuss a whole range of topics, including Peter’s professional journey and the…
Fard Johnmar, Founder of Enspektos, and Denise Pines, President of the Medical Board of California, discuss the concepts of “FemAging” and “ePatients”, and how COVID-19 has affected both of these. We explore an…
Natalie Yeadon, Co-Owner and Managing Director at Impetus Digital, provides insight on Elon Musk’s Neuralink and the Future of the Computer Brain Interface.
Learn how one of our clients used the Impetus InSite Platform to connect their MSLs with regional groups of physicians.
